CoChat

A slow transcription rate causes embryonic lethality and perturbs kinetic coupling of neuronal genes

Open access

Published version of a preprint

The DOI matches its Crossref record; 91 of the 92 references it cites were found in a registry or an index.

Abstract

The rate of RNA polymerase II (RNAPII) elongation has an important role in the control of alternative splicing (AS); however, the in vivo consequences of an altered elongation rate are unknown. Here, we generated mouse embryonic stem cells (ESCs) knocked in for a slow elongating form of RNAPII. We show that a reduced transcriptional elongation rate results in early embryonic lethality in mice. Focusing on neuronal differentiation as a model, we observed that slow elongation impairs development of the neural lineage from ESCs, which is accompanied by changes in AS and in gene expression along this pathway. In particular, we found a crucial role for RNAPII elongation rate in transcription and splicing of long neuronal genes involved in synapse signaling. The impact of the kinetic coupling of RNAPII elongation rate with AS is greater in ESC‐differentiated neurons than in pluripotent cells. Our results demonstrate the requirement for an appropriate transcriptional elongation rate to ensure proper gene expression and to regulate AS during development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.2018101244

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Generation of slow RNAPII knock‐in mutant mouse ESCs Cartoon depicting the mutagenesis strategy, including the genomic target locus, as well as the structure of the targeting vector. Arrows indicate location of primers used for genotyping.Restriction enzyme diagnostic test for the presence of the R749H mutation.Sequence trace of cDNA showing the presence of the heterozygous and homozygous R749H mutations.qRT–PCR with primers specific to both wild‐type and mutant RNAPII (left panel) or to the mutant form of RNAPII (right panel), confirming that only the slow version of RNAPII is expressed in homozygous slow/slow ESCs. The sequences of the respective forward primers are shown. The “WT/slow allele” primer is complementary to the sequence in exon 14 upstream of the mutation. The “slow allele only” primer has its 3′ end matching the mutated codon 749 and does not anneal to the WT DNA sequence. The mean ± SEM is plotted, n = 2.
Figure 1 Generation of slow RNAPII knock‐in mutant mouse ESCs Cartoon depicting the mutagenesis strategy, including the genomic target locus, as well as the structure of the targeting vector. Arrows indicate location of primers used for genotyping.Restriction enzyme diagnostic test for the presence of the R749H mutation.Sequence trace of cDNA showing the presence of the heterozygous and homozygous R749H mutations.qRT–PCR with primers specific to both wild‐type and mutant RNAPII (left panel) or to the mutant form of RNAPII (right panel), confirming that only the slow version of RNAPII is expressed in homozygous slow/slow ESCs. The sequences of the respective forward primers are shown. The “WT/slow allele” primer is complementary to the sequence in exon 14 upstream of the mutation. The “slow allele only” primer has its 3′ end matching the mutated codon 749 and does not anneal to the WT DNA sequence. The mean ± SEM is plotted, n = 2.CC BY · PubMed Central
Figure 2 CRISPR‐/Cas‐mediated generation of a slow RNAPII knock‐in mutant mouse ACartoon depicting the mutagenesis strategy, including the genomic target locus, as well as two repair templates, either introducing a silent mutation (silent oligo) or the R749H mutation (slow oligo). Multiple repair oligo templates were tested with different composition of silent restriction sites.B, CThe number of embryos/mice of different genotypes recovered after injecting a slow RNAPII repair oligo (B) or a 1:1 mixture of slow and silent RNAP II repair oligos (C) into E0.5 zygotes is shown in each table. The RNAPII genotypes and the stages at which embryos/mice were analyzed are indicated. * indicates P < 0.01 (Fisher's exact test relative to E3.5).
Figure 2 CRISPR‐/Cas‐mediated generation of a slow RNAPII knock‐in mutant mouse ACartoon depicting the mutagenesis strategy, including the genomic target locus, as well as two repair templates, either introducing a silent mutation (silent oligo) or the R749H mutation (slow oligo). Multiple repair oligo templates were tested with different composition of silent restriction sites.B, CThe number of embryos/mice of different genotypes recovered after injecting a slow RNAPII repair oligo (B) or a 1:1 mixture of slow and silent RNAP II repair oligos (C) into E0.5 zygotes is shown in each table. The RNAPII genotypes and the stages at which embryos/mice were analyzed are indicated. * indicates P < 0.01 (Fisher's exact test relative to E3.5).CC BY · PubMed Central
Figure EV1 Validation of the transcriptional elongation rate in ES mutant cell lines (related to Fig 3) Cartoon depicting the structure of Itpr1 and utrophin pre‐mRNAs, with primer pairs selected to monitor the appearance of selected intron–exon junctions indicated by arrows. Quantification of pre‐mRNA at different time points at the beginning, in the middle, and at the end of the gene displayed relative to cells not treated with DRB in WT/WT, WT/slow, and slow/slow cells (black, gray, and purple bars, respectively). The mean ± SEM is shown, n = 3.Time course of incorporation of 3H‐uridine in WT/WT or slow/slow cells. Time 0’ corresponds to time of DRB wash‐off. Mean ± SEM is plotted with *P < 0.05 as determined by t‐test, n = 3. In vitro transcription of a linearized plasmid using nuclear extracts from either WT/WT or slow/slow ES cells. The image shown is representative of 1 of 2 reproducible experiments.
Figure EV1 Validation of the transcriptional elongation rate in ES mutant cell lines (related to Fig 3) Cartoon depicting the structure of Itpr1 and utrophin pre‐mRNAs, with primer pairs selected to monitor the appearance of selected intron–exon junctions indicated by arrows. Quantification of pre‐mRNA at different time points at the beginning, in the middle, and at the end of the gene displayed relative to cells not treated with DRB in WT/WT, WT/slow, and slow/slow cells (black, gray, and purple bars, respectively). The mean ± SEM is shown, n = 3.Time course of incorporation of 3H‐uridine in WT/WT or slow/slow cells. Time 0’ corresponds to time of DRB wash‐off. Mean ± SEM is plotted with *P < 0.05 as determined by t‐test, n = 3. In vitro transcription of a linearized plasmid using nuclear extracts from either WT/WT or slow/slow ES cells. The image shown is representative of 1 of 2 reproducible experiments.CC BY · PubMed Central
Figure 3 Global analysis of transcription elongation rate in mouse ESCs by 4sU‐DRBseq ASchematic of the 4sU‐DRB‐seq labeling protocol.BMeta‐gene profile of normalized 4sU‐DRB‐seq reads in WT/WT and slow/slow ESCs.C, DDensity and violin plot of elongation rate (bases/min) calculated for genes common in all genotypes in WT/WT, WT/slow, and slow/slow ESCs. Box and whisker plot (5th–95th percentile) indicates median. Mann–Whitney test, ****P < 0.0001. Source data are available online for this figure.
Figure 3 Global analysis of transcription elongation rate in mouse ESCs by 4sU‐DRBseq ASchematic of the 4sU‐DRB‐seq labeling protocol.BMeta‐gene profile of normalized 4sU‐DRB‐seq reads in WT/WT and slow/slow ESCs.C, DDensity and violin plot of elongation rate (bases/min) calculated for genes common in all genotypes in WT/WT, WT/slow, and slow/slow ESCs. Box and whisker plot (5th–95th percentile) indicates median. Mann–Whitney test, ****P < 0.0001. Source data are available online for this figure.CC BY · PubMed Central
Figure EV2 Analysis of elongation rate in mouse ESCs by 4sU‐DRBseq (related to Fig 3) Example of wave progression in the Notch1 gene (reverse strand) following release from DRB block at 0, 5, and 15 min.Position of the 4sU‐DRB‐seq transcription wave‐front for common genes over time. Dashed lines indicate median wave‐front positions.Correlation of elongation rate measured in WT/WT, WT/slow, and slow/slow ESCs with mean expression. Correlation coefficients are 0.047, 0.003, and 0.015 (P = 2.1e‐10, 0.036, and 9.4e‐8), respectively.
Figure EV2 Analysis of elongation rate in mouse ESCs by 4sU‐DRBseq (related to Fig 3) Example of wave progression in the Notch1 gene (reverse strand) following release from DRB block at 0, 5, and 15 min.Position of the 4sU‐DRB‐seq transcription wave‐front for common genes over time. Dashed lines indicate median wave‐front positions.Correlation of elongation rate measured in WT/WT, WT/slow, and slow/slow ESCs with mean expression. Correlation coefficients are 0.047, 0.003, and 0.015 (P = 2.1e‐10, 0.036, and 9.4e‐8), respectively.CC BY · PubMed Central
Figure 4 Differentiation of WT and slow ESCs along the neural lineage Schematic of the neural differentiation system used in this study, indicating the relevant markers that define different stages of differentiation.Bright‐field images and analysis of NPC markers by immunofluorescence staining (Sox1 and Nestin) or RT–qPCR (Nestin and Pax6) (n = 3, mean ± SEM).Bright‐field images of aggregates.Bright‐field images and immunofluorescence staining for Nestin and neuronal marker Tuj1 in NSC cultures grown in EGF‐/FGF‐proliferating conditions. White arrows indicate NSCs and green arrows differentiated cells. Two small panels on the right are examples of Tuj1+ neuronal cells in slow/slow NSC cultures.Immunofluorescence staining for neuronal marker Tuj1 in neuronal cultures grown on poly‐ornithine/laminin at 21 days of differentiation.
Figure 4 Differentiation of WT and slow ESCs along the neural lineage Schematic of the neural differentiation system used in this study, indicating the relevant markers that define different stages of differentiation.Bright‐field images and analysis of NPC markers by immunofluorescence staining (Sox1 and Nestin) or RT–qPCR (Nestin and Pax6) (n = 3, mean ± SEM).Bright‐field images of aggregates.Bright‐field images and immunofluorescence staining for Nestin and neuronal marker Tuj1 in NSC cultures grown in EGF‐/FGF‐proliferating conditions. White arrows indicate NSCs and green arrows differentiated cells. Two small panels on the right are examples of Tuj1+ neuronal cells in slow/slow NSC cultures.Immunofluorescence staining for neuronal marker Tuj1 in neuronal cultures grown on poly‐ornithine/laminin at 21 days of differentiation.CC BY · PubMed Central
Figure EV3 Characterization of WT and slow ESCs differentiated to neurons (related to Fig 4) Immunofluorescence staining for neuronal markers Map2, Syn1, and NeuN in neurons cultured on poly‐ornithine‐/laminin‐coated plates.Expression of neuronal markers in neurons cultured on poly‐ornithine‐/laminin‐coated plates from RNA‐seq analysis, n = 3.
Figure EV3 Characterization of WT and slow ESCs differentiated to neurons (related to Fig 4) Immunofluorescence staining for neuronal markers Map2, Syn1, and NeuN in neurons cultured on poly‐ornithine‐/laminin‐coated plates.Expression of neuronal markers in neurons cultured on poly‐ornithine‐/laminin‐coated plates from RNA‐seq analysis, n = 3.CC BY · PubMed Central
Figure 5 The rate of transcriptional elongation influences alternative splicing decisions in ESCs and during neural differentiation Number of alternative splicing events that are sensitive to a slow elongation rate, including cassette exons, microexons, alternative 3′ or 5′ splice sites, and retained introns in ESCs and at different stages of neural differentiation. UP and DOWN refer to increased or decreased levels of a splicing event in slow/slow cells relative to WT cells with dPSI (percent spliced in) ≥ 10% and FDR < 0.05 when comparing regulated events to all detected events and retained (Total). Splicing was quantified using VAST‐TOOLS.RT–PCR analysis validation of selected alternatively spliced exons. RT–PCR was performed on total RNA from WT or slow/slow ESCs, NPCs, or neurons. PCR products were visualized and quantified by Bioanalyzer (Agilent). Images are representative of experiments performed in triplicate. The mean ± SEM is plotted with *P < 0.05, **P < 0.005, ***< 0.0001 as determined by t‐test. Source data are available online for this figure.
Figure 5 The rate of transcriptional elongation influences alternative splicing decisions in ESCs and during neural differentiation Number of alternative splicing events that are sensitive to a slow elongation rate, including cassette exons, microexons, alternative 3′ or 5′ splice sites, and retained introns in ESCs and at different stages of neural differentiation. UP and DOWN refer to increased or decreased levels of a splicing event in slow/slow cells relative to WT cells with dPSI (percent spliced in) ≥ 10% and FDR < 0.05 when comparing regulated events to all detected events and retained (Total). Splicing was quantified using VAST‐TOOLS.RT–PCR analysis validation of selected alternatively spliced exons. RT–PCR was performed on total RNA from WT or slow/slow ESCs, NPCs, or neurons. PCR products were visualized and quantified by Bioanalyzer (Agilent). Images are representative of experiments performed in triplicate. The mean ± SEM is plotted with *P < 0.05, **P < 0.005, ***< 0.0001 as determined by t‐test. Source data are available online for this figure.CC BY · PubMed Central
Figure EV4 Characterization of mRNAs differentially spliced in slow/slow cells (Related to Fig 5) Length of alternative exons and flanking introns in ESCs and neurons. Boxes delimit the first and third quartiles. The horizontal line represents the data medians. Whiskers are drawn down to the 5th and the 95th percentiles. Mann–Whitney test, P < 0.01 (*), 0.001 (**), 0.0001 (***).Example of RNA maps produced using matt for Nova1 and Fox for exons more included (blue) or less included (red) or unchanged (gray) in neurons, bold line represents P < 0.1. These maps reveal increased binding of these factors downstream of the regulated exon.
Figure EV4 Characterization of mRNAs differentially spliced in slow/slow cells (Related to Fig 5) Length of alternative exons and flanking introns in ESCs and neurons. Boxes delimit the first and third quartiles. The horizontal line represents the data medians. Whiskers are drawn down to the 5th and the 95th percentiles. Mann–Whitney test, P < 0.01 (*), 0.001 (**), 0.0001 (***).Example of RNA maps produced using matt for Nova1 and Fox for exons more included (blue) or less included (red) or unchanged (gray) in neurons, bold line represents P < 0.1. These maps reveal increased binding of these factors downstream of the regulated exon.CC BY · PubMed Central
Figure EV5 Correlation of gene expression and AS changes between WT and slow/slow cells (related to Fig 5) A–CCorrelation of changes in gene expression and AS (cassette exons, microexons and intron retention events) in slow/slow cells, as compared to WT cells, in (A) ESCs, (B) NPCs and (C) neurons. The y‐axis shows dPSI, which represents the difference in percent splicing inclusion between slow/slow and WT cells, while the x‐axis represents a log2‐fold change in expression between slow/slow and WT cells. Blue dots are for genes that change in expression (Changed DE), red dots are for differentially spliced pre‐mRNAs (Changed AS), and purple dots represent both differentially expressed and spliced genes. The relation between these two variables is represented by the regression line correlation coefficients r 2.
Figure EV5 Correlation of gene expression and AS changes between WT and slow/slow cells (related to Fig 5) A–CCorrelation of changes in gene expression and AS (cassette exons, microexons and intron retention events) in slow/slow cells, as compared to WT cells, in (A) ESCs, (B) NPCs and (C) neurons. The y‐axis shows dPSI, which represents the difference in percent splicing inclusion between slow/slow and WT cells, while the x‐axis represents a log2‐fold change in expression between slow/slow and WT cells. Blue dots are for genes that change in expression (Changed DE), red dots are for differentially spliced pre‐mRNAs (Changed AS), and purple dots represent both differentially expressed and spliced genes. The relation between these two variables is represented by the regression line correlation coefficients r 2.CC BY · PubMed Central
Figure 6 A slow RNAPII preferentially affects synaptic genes Gene ontology analysis of genes downregulated in slow/slow neurons showing the top‐ranked cellular component (CC), biological processes (BP), or molecular functions (MF) GO categories.Box plot showing the length of upregulated (UP), downregulated (DOWN), not affected genes (ALL), and pre‐mRNAs affected by alternative splicing (AE, for alternative exons) for ESCs (left panel); length of upregulated (UP), downregulated (DOWN), not affected genes (ALL), pre‐mRNAs affected by alternative splicing (AE, for alternative exons), and not affected genes that are only expressed in neurons (but not in ESCs) (ALL_notESC), for neurons (right panel). n.s., P > 0.05, **P < 0.005; ****P < 0.0001 as determined by Mann–Whitney t‐test. Boxes delimit the first and third quartiles. The horizontal lines represent the data medians. Whiskers are drawn down to the 1st and 99th percentiles.Percentage of genes that are downregulated in ESCs and neurons, plotted as a sliding window of 100 genes by length.
Figure 6 A slow RNAPII preferentially affects synaptic genes Gene ontology analysis of genes downregulated in slow/slow neurons showing the top‐ranked cellular component (CC), biological processes (BP), or molecular functions (MF) GO categories.Box plot showing the length of upregulated (UP), downregulated (DOWN), not affected genes (ALL), and pre‐mRNAs affected by alternative splicing (AE, for alternative exons) for ESCs (left panel); length of upregulated (UP), downregulated (DOWN), not affected genes (ALL), pre‐mRNAs affected by alternative splicing (AE, for alternative exons), and not affected genes that are only expressed in neurons (but not in ESCs) (ALL_notESC), for neurons (right panel). n.s., P > 0.05, **P < 0.005; ****P < 0.0001 as determined by Mann–Whitney t‐test. Boxes delimit the first and third quartiles. The horizontal lines represent the data medians. Whiskers are drawn down to the 1st and 99th percentiles.Percentage of genes that are downregulated in ESCs and neurons, plotted as a sliding window of 100 genes by length.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 91 references

Cited by

See all 63

Metadata

Authors
Maslon, M. M., Braunschweig, U., Aitken, S., Mann, A. R., Kilanowski, F., Hunter, C. J., Blencowe, B. J., Kornblihtt, A. R., Adams, I. R., & Cáceres, J. F.
Affiliations
  • Institute of Genetics and Cancer (GB)
  • University of Toronto (CA)
  • Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
Venue
The EMBO Journal
Published
2019-04-15
Volume
38
Issue
9
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2940424640
Cited by
63
References
92
Citations by year
2026: 3 · 2025: 10 · 2024: 8 · 2023: 6 · 2022: 11 · 2021: 9 · 2020: 11 · 2019: 5
FWCI
2.96
Type
journal article
Language
en
Open access
Licence
Locations
  • The EMBO Journal (publishedVersion, other-oa)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
Funders
  • Wellcome Trust Wellcome (095518/Z/11/Z)
  • RCUK|Medical Research Council (MRC)
  • Canadian Institutes of Health Research
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
Keywords
RNA polymerase II, embryonic lethality, mouse embryonic stem cells, neuronal differentiation, alternative splicing, gene expression regulation
MeSH terms
Animals, Cells, Cultured, Female, Gene Expression Regulation, Male, Mice, Inbred C57BL, Mutation, RNA Polymerase II, Transcription, Genetic, Alternative Splicing, Mice, Knockout, Cell Lineage, Mice, Embryonic Stem Cells, Neural Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A slow transcription rate causes embryonic lethality and perturbs kinetic coupling of neuronal genes. https://app.cochat.ai/papers/10.15252/embj.2018101244
The paper
Maslon, M. M., Braunschweig, U., Aitken, S., Mann, A. R., Kilanowski, F., Hunter, C. J., Blencowe, B. J., Kornblihtt, A. R., Adams, I. R., & Cáceres, J. F. (2019). A slow transcription rate causes embryonic lethality and perturbs kinetic coupling of neuronal genes. The EMBO Journal. https://doi.org/10.15252/embj.2018101244

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.